Bowman P, Sulen Å, Barbetti F, et al. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. Lancet Diabetes Endocrinol 2018; 6: 637–46—In the appendix of this Article, the name of a member of the Neonatal Diabetes International Collaborative Group, Sorin Ioacara, was spelled incorrectly. This correction has been made to the online version as of Aug 21, 2018.
. 2018 Sep;6(9):e17. doi: 10.1016/S2213-8587(18)30238-9
Correction to Lancet Diabetes Endocrinol 2018; 6: 637–46
© 2018 The Author. Published by Elsevier Ltd.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
PMCID: PMC6418408 PMID: 30143191
This corrects the article "Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study" on page 637.